Cargando…
Convergent Epigenetic Evolution Drives Relapse in Acute Myeloid Leukemia
Relapse of acute myeloid leukemia (AML) is highly aggressive and often treatment refractory. We analyzed previously published AML relapse cohorts and found that 40% of relapses occur without changes in driver mutations, suggesting that non-genetic mechanisms drive relapse in a large proportion of ca...
Autores principales: | Nuno, Kevin A., Azizi, Armon, Köhnke, Thomas, Lareau, Caleb A., Ediwirickrema, Asiri, Ryan Corces, M., Satpathy, Ansuman T., Majeti, Ravindra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10592718/ https://www.ncbi.nlm.nih.gov/pubmed/37873452 http://dx.doi.org/10.1101/2023.10.10.561642 |
Ejemplares similares
-
Preleukemic Hematopoietic Stem Cells in Human Acute Myeloid Leukemia
por: Corces, M. Ryan, et al.
Publicado: (2017) -
Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia
por: Benard, Brooks A., et al.
Publicado: (2021) -
RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition
por: Fan, Amy C., et al.
Publicado: (2023) -
The TRACE-Seq method tracks recombination alleles and identifies clonal reconstitution dynamics of gene targeted human hematopoietic stem cells
por: Sharma, Rajiv, et al.
Publicado: (2021) -
CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
por: Farge, Thomas, et al.
Publicado: (2023)